Cancer drug Avastin shows early promise as tumour imaging agent - UPDATE
This article was originally published in Clinica
Executive Summary
Avastin (bevacizumab), the blockbuster anticancer drug developed by Roche and Genentech, could have a new application – imaging tumours. Scientists have found that it is better than the gold standard, 18-fluorodeoxyglucose (18FDG) for visualising pancreatic, breast and lung cancers in mice.